Shares of Biocept Inc. BIOC +0.74% plunge 42% bulky In early trading Monday, the liquid cancer-testing provider announced a stock offering priced at a steep discount. … the pricing was announced after shares surged 169% on Friday.

Is BIOC stock worth buying?

Biocept gets Buy consensus rating. The company’s average rating is 3.00, based on 1 Buy rating, No Holds, and No Sells.

Will Biocept rise?

Will Biocept share price go up/up/up? Yes. BIOC’s share price can go from $3.990 to $4.679 in one year.

How high can Biocept go?

stock price forecast

1 analyst providing a 12-month price forecast for Biocept Inc Target median 12.00the highest estimate is 12.00, and the lowest estimate is 12.00.

Will BIOC split in reverse?

(BIOC) will conduct a ten-for-one (1-10) reverse split of its common stock.A reverse stock split would be Effective Tuesday, September 8, 2020. Combined with the reverse split, the CUSIP number will be changed to 09072V501.

🚨📈📉 Is SNAPCHAT ($SNAP) stock a buy? ! SNAP drops more than 30% earnings!high growth stocks

35 related questions found

Why is Bioc up?

increase by Mainly attributable to COVID-19 testing. « This is the statement that drives shorting. … covid tests keep the bioc running.

Will Zom stock rise?

In addition, ZOM Shares are still up more than 350% in the 12 months to July 2, 2021…But if the company can capture any significant portion of the nearly $3 billion market, buying shares at 78 cents seems like a steal. This is the spread that risk tolerance traders can get behind.

What is the Zom stock price forecast?

stock price forecast

1 analyst providing 12-month price forecasts for Zomedica Corp The median target is 1.20, the highest estimate is 1.20, and the lowest estimate is 1.20. The median estimate is a +125.14% increase from the last price of 0.53.

Will Zomedica go out of business?

indeed, Zomedica closed in 2018 Less than $2 million in cash. It burned through nearly $12 million that year. The Form 10-K filed with the SEC contains a « going concern » notice warning investors that the company may not get through 2019 without filing for bankruptcy.

Is Zomedica for sale?

FDA Approval for Zomedica

Zomedica’s Truforma platform, which generates diagnostic results in the field, will be available in March 2021. Sales are still small (Just over $14,000 in the first quarter) because the company works on an internal marketing team.

Is Zomedica Shorted?

What is Zomedica’s current short interest? … 10.54% of Zomedica is currently shorted.

Is Zomedica a good company?

Zomedica Pharmaceuticals (NYSEMKT: ZOM) has been one of the most attractive (and top-performing) companies Healthcare Penny Stocks In the past year. In fact, investing $10,000 into its stock last March would be worth more than $85,000 today. … Zomedica is now a billion dollar company.

Is Zomedica Underrated?

The company’s last minute price was $0.51. Zomedica Pharmaceuticals has a pretty high valuation. … in general, we encourage purchases undervalued securities And ditch overvalued securities because at some point the asset price and its ongoing real value will grow together.

Is Zomedica making money?

and no product revenueWith annual losses of $16.9 million and assets of about $90 million, Zomedica is apparently still in the early stages of commercializing Truforma, a device that measures cortisol levels in dogs and cats using body acoustic wave detection technology.

Is ZOM stock a good long-term investment?

ZOM stock is a good long-term investment.

The market opportunity for companion animal diagnostics is expected to grow from $1.7 billion in 2019 to $2.8 billion in 2024, ZOM said in its filing, citing data from MarketsandMarkets. Notably, Truforma is a recurring revenue opportunity for Zomedica.

How much is Zomedica shorted?

In theory, the more short positions that are currently open, the faster you can cover positions.According to the latest financial disclosures, Zomedica Pharmaceuticals Corp has a short-to-short ratio of 2.69 times.

What is the Short Ratio?

The short-term interest rate is Simple formula that divides the number of shares shorted by the average daily trading volume of the stockIn short, the ratio can help investors quickly see if a stock is heavily shorted or not shorted compared to its average daily trading volume.

Can you short AMC stock?

AMC’s short-term borrowing costs are currently 0.90%, pass. Stonk-O-Tracker on 9/13. AMC stock is getting harder to borrow.

What’s wrong with Zomedica?

ZOM stock slipped because of Poor sales growth Its veterinary diagnostic equipment had even worse financial results. Not only has Zomedica not been generating any profits, but the company has yet to earn any revenue. For all of 2020, Zomedica did not report any revenue.

Why is Zomedica down today?

Chief executive Robert Cohen said the move was due to « changes in our current dealerships that we believe have impacted their capabilities. promote our products efficient. Those words may have taken investors by surprise, many of whom decided to sell their shares. Shares of Zomedica fell sharply on Thursday.

What is a reverse stock split?

A reverse stock split is Measures taken by the company to reduce its number of shares outstanding in the market. Existing shares are consolidated into fewer, proportionally more valuable shares, pushing up the company’s share price.